ALOMONE LABS Non-Antibody Products — page 46 of 47
Non-Antibody Products
Page 46 of 47
| Name | Description | Size | Catalog # | |
|---|---|---|---|---|
| Urotoxin | Urotoxin is a potent KV1.2 channel blocker. The toxin also blocks KV1.1, K… | 0.1 mg | STU-200 | More Info |
| Urotoxin | Urotoxin is a potent KV1.2 channel blocker. The toxin also blocks KV1.1, K… | 0.5 mg | STU-200 | More Info |
| Urotoxin | Urotoxin is a potent KV1.2 channel blocker. The toxin also blocks KV1.1, K… | 1 mg | STU-200 | More Info |
| Urotoxin | Urotoxin is a potent KV1.2 channel blocker. The toxin also blocks KV1.1, K… | 10 mg | STU-200 | More Info |
| Urotoxin | Urotoxin is a potent KV1.2 channel blocker. The toxin also blocks KV1.1, K… | 5 mg | STU-200 | More Info |
| Valerenic acid | Valerenic acid is a positive allosteric modulator of GABAA receptors that… | 1 mg | V-140 | More Info |
| Valerenic acid | Valerenic acid is a positive allosteric modulator of GABAA receptors that… | 10 mg | V-140 | More Info |
| Valerenic acid | Valerenic acid is a positive allosteric modulator of GABAA receptors that… | 25 mg | V-140 | More Info |
| Valerenic acid | Valerenic acid is a positive allosteric modulator of GABAA receptors that… | 5 mg | V-140 | More Info |
| Valsartan | Valsartan is an Angiotensin II type-1 receptor antagonist1. Synthetic. Pur… | 1 g | V-120 | More Info |
| Valsartan | Valsartan is an Angiotensin II type-1 receptor antagonist1. Synthetic. Pur… | 100 mg | V-120 | More Info |
| Valsartan | Valsartan is an Angiotensin II type-1 receptor antagonist1. Synthetic. Pur… | 50 mg | V-120 | More Info |
| Valsartan | Valsartan is an Angiotensin II type-1 receptor antagonist1. Synthetic. Pur… | 500 mg | V-120 | More Info |
| Varenicline tartrate | Varenicline tartrate is a partial agonist of α4/β2 nicotinic ac… | 10 mg | V-105 | More Info |
| Varenicline tartrate | Varenicline tartrate is a partial agonist of α4/β2 nicotinic ac… | 25 mg | V-105 | More Info |
| Varenicline tartrate | Varenicline tartrate is a partial agonist of α4/β2 nicotinic ac… | 5 mg | V-105 | More Info |
| Varenicline tartrate | Varenicline tartrate is a partial agonist of α4/β2 nicotinic ac… | 50 mg | V-105 | More Info |
| Verapamil HCl | Verapamil HCl is a phenylalkylamine that acts as an L-type, voltage-gated… | 1 g | V-100 | More Info |
| Verapamil HCl | Verapamil HCl is a phenylalkylamine that acts as an L-type, voltage-gated… | 10 g | V-100 | More Info |
| Verapamil HCl | Verapamil HCl is a phenylalkylamine that acts as an L-type, voltage-gated… | 5 g | V-100 | More Info |
| Veratridine | Veratridine is an alkaloid which is a potent modulator of voltage-dependen… | 10 mg | V-110 | More Info |
| Veratridine | Veratridine is an alkaloid which is a potent modulator of voltage-dependen… | 25 mg | V-110 | More Info |
| Veratridine | Veratridine is an alkaloid which is a potent modulator of voltage-dependen… | 5 mg | V-110 | More Info |
| Veratridine | Veratridine is an alkaloid which is a potent modulator of voltage-dependen… | 50 mg | V-110 | More Info |
| Verruculogen | Verruculogen is a selective blocker of KCa1.1 (BK) channel. It belongs to… | 0.51 mg | V-500 | More Info |
| Verruculogen | Verruculogen is a selective blocker of KCa1.1 (BK) channel. It belongs to… | 1 mg | V-500 | More Info |
| Verruculogen | Verruculogen is a selective blocker of KCa1.1 (BK) channel. It belongs to… | 5 mg | V-500 | More Info |
| VSTX3 | VSTX3 inhibits voltage-gated Na+ channels NaV1.3, NaV1.7 and NaV1.81. Synt… | 0.1 mg | STT-350 | More Info |
| VSTX3 | VSTX3 inhibits voltage-gated Na+ channels NaV1.3, NaV1.7 and NaV1.81. Synt… | 0.5 mg | STT-350 | More Info |
| VSTX3 | VSTX3 inhibits voltage-gated Na+ channels NaV1.3, NaV1.7 and NaV1.81. Synt… | 1 mg | STT-350 | More Info |
| VSTX3 | VSTX3 inhibits voltage-gated Na+ channels NaV1.3, NaV1.7 and NaV1.81. Synt… | 10 mg | STT-350 | More Info |
| VSTX3 | VSTX3 inhibits voltage-gated Na+ channels NaV1.3, NaV1.7 and NaV1.81. Synt… | 5 mg | STT-350 | More Info |
| VSTX3 | VSTX3 inhibits voltage-gated Na+ channels NaV1.3, NaV1.7 and NaV1.81. Synt… | 50 µg | STT-350 | More Info |
| VU0529331 | VU0529331 is a novel activator of homomeric and of non-GIRK1-containing G-… | 10 mg | V-155 | More Info |
| VU0529331 | VU0529331 is a novel activator of homomeric and of non-GIRK1-containing G-… | 25 mg | V-155 | More Info |
| VU0529331 | VU0529331 is a novel activator of homomeric and of non-GIRK1-containing G-… | 5 mg | V-155 | More Info |
| VU0529331 | VU0529331 is a novel activator of homomeric and of non-GIRK1-containing G-… | 50 mg | V-155 | More Info |
| VU591 | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥99%. MW: 368.3 | 10 mg | V-125 | More Info |
| VU591 | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥99%. MW: 368.3 | 25 mg | V-125 | More Info |
| VU591 | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥99%. MW: 368.3 | 5 mg | V-125 | More Info |
| VU590 dihydrochloride | VU590 inhibits ROMK1 channels in a dose-dependent manner with an IC50 of 2… | 10 mg | V-130 | More Info |
| VU590 dihydrochloride | VU590 inhibits ROMK1 channels in a dose-dependent manner with an IC50 of 2… | 25 mg | V-130 | More Info |
| VU590 dihydrochloride | VU590 inhibits ROMK1 channels in a dose-dependent manner with an IC50 of 2… | 5 mg | V-130 | More Info |
| VU590 dihydrochloride | VU590 inhibits ROMK1 channels in a dose-dependent manner with an IC50 of 2… | 50 mg | V-130 | More Info |
| VUF 10166 | VUF 10166 is a potent and selective 5-HT3A and B receptor antagonist1. Syn… | 10 mg | V-115 | More Info |
| VUF 10166 | VUF 10166 is a potent and selective 5-HT3A and B receptor antagonist1. Syn… | 25 mg | V-115 | More Info |
| VUF 10166 | VUF 10166 is a potent and selective 5-HT3A and B receptor antagonist1. Syn… | 5 mg | V-115 | More Info |
| VUF 10166 | VUF 10166 is a potent and selective 5-HT3A and B receptor antagonist1. Syn… | 50 mg | V-115 | More Info |
| VU591 hydrochloride | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥98.5%. MW: 404.8 | 10 mg | V-126 | More Info |
| VU591 hydrochloride | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥98.5%. MW: 404.8 | 25 mg | V-126 | More Info |
| VU591 hydrochloride | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥98.5%. MW: 404.8 | 5 mg | V-126 | More Info |
| VU591 hydrochloride | VU591 is a Kir1.1 channel blocker1. Synthetic. Purity ≥98.5%. MW: 404.8 | 50 mg | V-126 | More Info |
| Waglerin-1 | Waglerin-1 blocks ε subunit of muscle adult nAChR and modulates ro… | 1 mg | STW-001 | More Info |
| Waglerin-1 | Waglerin-1 blocks ε subunit of muscle adult nAChR and modulates ro… | 10 mg | STW-001 | More Info |
| Waglerin-1 | Waglerin-1 blocks ε subunit of muscle adult nAChR and modulates ro… | 25 mg | STW-001 | More Info |
| Waglerin-1 | Waglerin-1 blocks ε subunit of muscle adult nAChR and modulates ro… | 5 mg | STW-001 | More Info |
| Wasabi Receptor Toxin | Wasabi Receptor Toxin is a cell penetrating peptide toxin activator of TRP… | 0.1 mg | STW-200 | More Info |
| Wasabi Receptor Toxin | Wasabi Receptor Toxin is a cell penetrating peptide toxin activator of TRP… | 0.5 mg | STW-200 | More Info |
| Wasabi Receptor Toxin | Wasabi Receptor Toxin is a cell penetrating peptide toxin activator of TRP… | 1 mg | STW-200 | More Info |
| Wasabi Receptor Toxin | Wasabi Receptor Toxin is a cell penetrating peptide toxin activator of TRP… | 10 mg | STW-200 | More Info |
| Wasabi Receptor Toxin | Wasabi Receptor Toxin is a cell penetrating peptide toxin activator of TRP… | 5 mg | STW-200 | More Info |
| WKYMVM | WKYMVM is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 1 mg | GPW-100 | More Info |
| WKYMVM | WKYMVM is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 10 mg | GPW-100 | More Info |
| WKYMVM | WKYMVM is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 25 mg | GPW-100 | More Info |
| WKYMVM | WKYMVM is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 5 mg | GPW-100 | More Info |
| WKYMVm | WKYMVm is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 0.5 mg | GPW-105 | More Info |
| WKYMVm | WKYMVm is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 1 mg | GPW-105 | More Info |
| WKYMVm | WKYMVm is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 10 mg | GPW-105 | More Info |
| WKYMVm | WKYMVm is a selective agonist of the formyl peptide receptors (FPR2 and FP… | 5 mg | GPW-105 | More Info |
| Wortmannin | Wortmannin is a potent and specific inhibitor of PI3-kinase1. In PC12 cell… | 1 mg | W-400 | More Info |
| Wortmannin | Wortmannin is a potent and specific inhibitor of PI3-kinase1. In PC12 cell… | 5 mg | W-400 | More Info |
| Wortmannin | Wortmannin is a potent and specific inhibitor of PI3-kinase1. In PC12 cell… | 5 x 5 mg | W-400 | More Info |
| WRW4 | WRW4 is a selective and potent antagonist of the formyl peptide receptor (… | 0.5 mg | GPW-110 | More Info |
| WRW4 | WRW4 is a selective and potent antagonist of the formyl peptide receptor (… | 1 mg | GPW-110 | More Info |
| WRW4 | WRW4 is a selective and potent antagonist of the formyl peptide receptor (… | 5 mg | GPW-110 | More Info |
ALOMONE LABS
ALOMONE LABS
Jerusalem BioPark (JBP), Hadassah Ein Kerem
PO Box 4287
Jerusalem, 9104201 ISRAEL
P: +972-2-587-2202
F: +972-2-587-1101
info@alomone.com
http://www.alomone.com
U.S.A. OFFICE
Toll free phone: 1800-618-1644 / 1800-791-3904
Toll free fax: 1888-454-7276 / 1800-791-3912
Return to Profile